Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32750 participants
INTERVENTIONAL
2020-10-25
2023-08-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Communities Fighting COVID Return to School
NCT05150860
Protecting Our Community: COVID-19 Testing
NCT04866303
Community-engaged Optimization of COVID-19 Rapid Evaluation And TEsting Experiences
NCT05894655
Evaluation of the Performance of Rapid Diagnostics for SARS-CoV-2 Self-testing in the Hands of Untrained
NCT05605769
Monitoring Patients for Developing Communicable and Opportunistic Infections and for Responding to Therapy
NCT00001477
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
At home testing (Aim 1)
High-risk friends and family of contacts exposed to COVID-19 will be provided with COVID-19 testing provided at home by a healthcare worker.
COVID-19 Testing Home-based (Aim 1)
Implementation of Antigen and PCR testing at participant homes
Mobile testing (Aim 1)
High-risk friends and family of contacts exposed to COVID-19 will be referred to study operated mobile testing sites in the community for COVID-19 testing.
COVID-19 Testing Mobile (Aim 1)
Implementation of Antigen and PCR testing at mobile test sites
Mobile testing approach 1 (Aim 2)
Mobile testing utilizing active outreach
COVID-19 Testing Mobile Approach 1 (Aim 2)
Implementation of Antigen and PCR testing at mobile test sites - active outreach
Mobile testing approach 2 (Aim 2)
Mobile testing utilizing baseline outreach approaches
COVID-19 Testing Mobile Approach 2 (Aim 2)
Implementation of Antigen and PCR testing at mobile test sites - baseline outreach
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
COVID-19 Testing Home-based (Aim 1)
Implementation of Antigen and PCR testing at participant homes
COVID-19 Testing Mobile (Aim 1)
Implementation of Antigen and PCR testing at mobile test sites
COVID-19 Testing Mobile Approach 1 (Aim 2)
Implementation of Antigen and PCR testing at mobile test sites - active outreach
COVID-19 Testing Mobile Approach 2 (Aim 2)
Implementation of Antigen and PCR testing at mobile test sites - baseline outreach
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
6 Years
120 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
San Diego State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Susan M Kiene
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Susan M Kiene, PhD
Role: PRINCIPAL_INVESTIGATOR
San Diego State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Contact Households
San Diego, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HS-2020-0186
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.